首页|双歧杆菌四联活菌片联合蒙脱石散方案对腹泻患儿的治疗及预后评价

双歧杆菌四联活菌片联合蒙脱石散方案对腹泻患儿的治疗及预后评价

扫码查看
目的 探究蒙脱石散与双歧杆菌四联活菌片联合方案在小儿腹泻中的疗效及安全性.方法 回顾性选取2022年6月—2023年6月广州医科大学附属妇女儿童医疗中心收治的120例腹泻患儿的诊疗资料,按照不同治疗方案分为对照组和观察组,各60例.对照组行蒙脱石散治疗,观察组加用双歧杆菌四联活菌片.对比两组临床疗效、临床表征恢复时间、症状评分、轮状病毒和腺病毒及诺如病毒转阴情况、不良反应发生情况.结果 观察组治疗总有效率高于对照组(96.67%vs 83.33%),差异有统计学意义(χ2=5.926,P<0.05).观察组的体温恢复时间、大便次数及性状恢复时间、腹痛消失时间均短于对照组,差异有统计学意义(P均<0.05).治疗后,两组的症状积分均优于治疗前,且观察组优于对照组,差异有统计学意义(P均<0.05).观察组轮状病毒、腺病毒转阴率高于对照组,差异有统计学意义(P均<0.05).两组的不良反应发生率比较,差异无统计学意义(P>0.05).结论 蒙脱石散+双歧杆菌四联活菌片疗法可缓解腹泻患儿临床表征和症状,有利于病毒转阴,安全性高,疗效可靠.
Evaluation of the Treatment and Prognosis of Children with Diarrhea by Bifidobacterium Bifidum Quadruple Bacteria Tablets Combined with Montmorillonite Powder Regimen
Objective To investigate the efficacy and safety of the combination of montmorillonite powder and bifido-bacterium bifidum quadruple bacterial tablets in pediatric diarrhea.Methods The diagnosis and treatment data of 120 children with diarrhea admitted to Women and Children's Medical Center Affiliated to Guangzhou Medical University from June 2022 to June 2023 were retrospectively selected.According to different treatment plans,they were divided into control group and observation group,with 60 cases in each group.The control group was treated with montmoril-lonite powder,and the observation group was treated with bifidobacterium bifidum viable tablets.The clinical efficacy,recovery time of clinical signs,symptom score,negative conversion of rotavirus,adenovirus and norovirus and occur-rence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was higher than that of the control group(96.67%vs 83.33%),and the difference was statistically significant(χ2=5.926,P<0.05).The recovery time of body temperature,the recovery time of stool frequency and character,and the disappearance time of abdominal pain in the observation group were shorter than those in the control group,and the differences were statistically significant(all P<0.05).After treatment,the symptom score of both groups was better than that before treatment,and the observation group was better than the control group,and the differences were statis-tically significant(all P<0.05).The negative conversion rate of rotavirus and adenovirus in the observation group was higher than that of the control group,and the differences were statistically significant(both P<0.05).There was no sig-nificant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Montmorillon-ite powder plus bifidobacterium bifidum quadruple bacterial tablets therapy can relieve the clinical characteristics and symptoms of children with diarrhea,and is conducive to virus negative transformation,with high safety and reliable ef-ficacy.

DiarrheaMontmorillonite powderBifidobacterium bifidum quadruple bacterial tabletsRotavirusAdverse effects

曾军、梁燕

展开 >

广州医科大学附属妇女儿童医疗中心,广东广州 510120

腹泻 蒙脱石散 双歧杆菌四联活菌片 轮状病毒 不良反应

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(10)